Thursday 6 May 2021
Home      All news      Contact us      RSS      India
business-standard - 16 days ago

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott s Duphaston


Latest News
Hashtags:   

Mankind

 | 

Pharma

 | 

revenue

 | 

chronic

 | 

therapy

 | 

drugs

 | 

years

 | 

Sources